发明授权
US07022697B2 4-(Oxadiazol-3-yl)-1,4-diazabicyclo[3.2.2]-nonane derivatives, preparation and therapeutic use thereof
有权
4-（恶二唑-3-基）-1,4-二氮杂双环[3.2.2] - 壬烷衍生物，其制备和治疗用途
![4-(Oxadiazol-3-yl)-1,4-diazabicyclo[3.2.2]-nonane derivatives, preparation and therapeutic use thereof](/docs/US/2006-04-04/US07022697B2/abs.jpg.600x600.jpg)
- 专利标题： 4-(Oxadiazol-3-yl)-1,4-diazabicyclo[3.2.2]-nonane derivatives, preparation and therapeutic use thereof
- 专利标题（中）： 4-（恶二唑-3-基）-1,4-二氮杂双环[3.2.2] - 壬烷衍生物，其制备和治疗用途
-
申请号： US10495891申请日： 2002-11-21
-
公开(公告)号： US07022697B2公开(公告)日： 2006-04-04
- 发明人: Frédéric Galli , Odile Leclerc , Alistair Lochead
- 申请人： Frédéric Galli , Odile Leclerc , Alistair Lochead
- 申请人地址： FR Paris
- 专利权人： Sanofi-aventis
- 当前专利权人： Sanofi-aventis
- 当前专利权人地址： FR Paris
- 代理商 Balaram Gupta
- 优先权： FR0115153 20011123
- 国际申请： PCT/FR02/03985 WO 20021121
- 国际公布： WO03/044019 WO 20030530
- 主分类号： A61P25/00
- IPC分类号： A61P25/00 ; A61K31/55 ; C07D471/08
![4-(Oxadiazol-3-yl)-1,4-diazabicyclo[3.2.2]-nonane derivatives, preparation and therapeutic use thereof](/abs-image/US/2006/04/04/US07022697B2/abs.jpg.150x150.jpg)
摘要：
The invention relates to compounds of the Formula I, to pharmaceutical compositions comprising them, and to the method of use thereof in the treatment or prevention of disorders linked to a dysfunction of the nicotinic receptors.